Top Pharmaceuticals stocks in Europe
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
NOVO BNovo Nordisk A/S | DKK4.34tn | 49.42 | 0.96% |
AZNAstraZeneca | £194.65bn | 44.6 | 1.81% |
ROGRoche Holding AG | CH₣189.82bn | 13.23 | 4.03% |
RORoche Holding AG | CH₣189.82bn | 14.75 | 3.62% |
NOVNNovartis AG | CH₣185.85bn | 18.64 | 3.7% |
SANSanofi SA | €114.04bn | 17.25 | 4.13% |
GSKGSK | £67.52bn | 12.9 | 3.62% |
MRKMerck KGaA | €74.48bn | 23.76 | 1.28% |
HLNHALEON | £30.16bn | 21.38 | 1.82% |
BAYNBayer AG | €27.60bn | 21.99 | 0.39% |
UCBUCB SA | €24.67bn | 92.95 | 0.73% |
SDZSandoz AG | CH₣13.61bn | 12.53 | 1.51% |
RECRecordati Industria Chimica E Farmaceutica SpA | €10.26bn | 27.03 | 2.41% |
IPNIpsen SA | €10.16bn | 23.37 | 0.98% |
SOBISwedish Orphan Biovitrum AB (publ) | SEK95.50bn | 36.03 | n/a |
GRFGrifols SA | €6.35bn | 33.24 | n/a |
ORNBVOrion Oyj | €5.47bn | 25.17 | 4.16% |
DPHDechra Pharmaceuticals | £4.40bn | 67.15 | n/a |
HIKHikma Pharmaceuticals | £4.32bn | 11.21 | 2.93% |
CLS1McKesson Europe AG | €4.96bn | n/a | n/a |